Clinical research

Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III): a randomised comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions

EuroIntervention 2013;9:841-853 published online ahead of print April 2013. DOI: 10.4244/EIJV9I7A138

Ben J.L. Van den Branden
Ben J.L. Van den Branden1, MD, PhD; Koen Teeuwen1, MD; Jacques J. Koolen2, MD, PhD; René J. van der Schaaf3, MD, PhD; José P.S. Henriques4, MD, PhD; Jan G.P. Tijssen5, MD, PhD; Johannes C. Kelder6, MD, PhD; Paul H.M.J. Vermeersch7, MD, PhD; Benno J.W.M. Rensing1, MD, PhD; Maarten J. Suttorp1*, MD, PhD
1. Department of Interventional Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands; 2. Department of Interventional Cardiology, Catharina Hospital, Eindhoven, The Netherlands; 3. Department of Interventional Cardiology, Onze

Aims: We investigated whether sirolimus-eluting stents (SES) are superior to next-generation zotarolimus-eluting stents (ZES) in treating patien

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

ctoclinical researchangioplasty
Read next article
Crossing chronic total occlusions with the Ocelot system: the initial European experience

Latest news